National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)

Rapid Review 

Commenced Completed Outcome
23rd October 2012 26th October 2012 Full Pharmacoeconomic Evaluation Not Recommended